Biopsy Devices Companies
Biopsy devices are used to collect tissue samples for diagnostic purposes, helping clinicians identify and analyze abnormalities or diseases. These devices are crucial in various medical fields, including oncology.
Biopsy devices are used to collect tissue samples for diagnostic purposes, helping clinicians identify and analyze abnormalities or diseases. These devices are crucial in various medical fields, including oncology.
Latest Biopsy devices Companies Updates:
Olympus finalized its acquisition of Odin Medical Ltd., a UK-based cloud-AI endoscopy company, strengthening its position in AI-assisted biopsy technologies. (Dec 2022)
Exact Sciences received FDA approval for its Exinia Genomic Prostate Test, a liquid biopsy test to detect early-stage prostate cancer through gene expression analysis. (Nov 2023)
Boston Scientific launched its Indigo™ Aspiration Catheter, a novel device designed for transhepatic and transjugular procedures, improving maneuverability and tissue aspiration for accurate biopsies. (Jan 10, 2024)
Medtronic announced its MicroPulse™ Tissue Acquisition System, a minimally invasive lung biopsy device with automated needle control for improved precision and patient comfort. (Jan 4, 2024)
List of Biopsy devices Key companies in the market:
Biopsy Devices Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)